We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,214
Reduced
3,562
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THACU
9101
DELISTED
Thrive Acquisition Corporation Unit
THACU
$5.46K ﹤0.01%
528
INST
9102
DELISTED
Instructure Holdings, Inc.
INST
$5.46K ﹤0.01%
233
-845
-78% -$19.7K
MFUL icon
9103
Mindful Conservative ETF
MFUL
$7.3M
$5.46K ﹤0.01%
254
-28
-10% -$601
RBT
9104
DELISTED
Rubicon Technologies, Inc.
RBT
$5.38K ﹤0.01%
+378
New +$5.97K
PCTI
9105
DELISTED
PCTEL, Inc. Common Stock
PCTI
$5.38K ﹤0.01%
1,252
+1,132
+943% +$5.05K
GIACU
9106
DELISTED
Gesher I Acquisition Corp.Unit
GIACU
$5.38K ﹤0.01%
541
PLUR icon
9107
Pluri
PLUR
$19.5M
$5.37K ﹤0.01%
714
+536
+301% +$3.49K
HPCO
9108
DELISTED
Hempacco Co., Inc. Common Stock
HPCO
$5.37K ﹤0.01%
655
-853
-57% -$14.3K
BYTSU
9109
DELISTED
BYTE Acquisition Corp. Units
BYTSU
$5.36K ﹤0.01%
533
TMBR
9110
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$5.36K ﹤0.01%
3,063
+2,168
+242% +$5.27K
BATL icon
9111
Battalion Oil
BATL
$29.7M
$5.36K ﹤0.01%
552
+151
+38% +$1.79K
TCBP
9112
DELISTED
TC BioPharm (Holdings) plc American Depositary Shares
TCBP
0
CULP icon
9113
Culp Inc
CULP
$44.8M
$5.33K ﹤0.01%
1,162
+728
+168% +$3.44K
CARV
9114
DELISTED
Carver Bancorp
CARV
$5.33K ﹤0.01%
1,297
-4,807
-79% -$19.6K
NOVV
9115
DELISTED
Nova Vision Acquisition Corp. Ordinary share
NOVV
$5.32K ﹤0.01%
509
-3
-0.6% -$31
CANF
9116
Can-Fite BioPharma American Depositary Shares
CANF
$7.63M
$5.31K ﹤0.01%
44
-43
-49% -$6.67K
SKGRU
9117
DELISTED
SK Growth Opportunities Corporation Unit
SKGRU
$5.3K ﹤0.01%
521
IMV
9118
DELISTED
IMV Inc. Common Shares
IMV
$5.29K ﹤0.01%
2,176
+2,004
+1,165% +$6.43K
BZFD icon
9119
BuzzFeed
BZFD
$94.1M
$5.27K ﹤0.01%
1,910
-440
-19% -$2.54K
VRCA icon
9120
Verrica Pharmaceuticals
VRCA
$92.1M
$5.26K ﹤0.01%
191
-360
-65% -$9.61K
XSHQ icon
9121
Invesco S&P SmallCap Quality ETF
XSHQ
$321M
$5.25K ﹤0.01%
161
-654
-80% -$21.9K
LEV.WS.A
9122
DELISTED
The Lion Electric Company Warrants to purchase common shares
LEV.WS.A
$5.25K ﹤0.01%
+7,500
New +$4.34K
NOGN
9123
DELISTED
Nogin, Inc. Common Stock
NOGN
$5.25K ﹤0.01%
+341
New +$5.46K
SRGA
9124
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$5.25K ﹤0.01%
2,636
+1,297
+97% +$3.2K
EEMO icon
9125
Invesco S&P Emerging Markets Momentum ETF
EEMO
$23.7M
$5.23K ﹤0.01%
379
-200
-35% -$2.82K

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.